Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by wasagastaron Jun 15, 2017 8:53am
136 Views
Post# 26365184

RE:All fine & dandy

RE:All fine & dandy
bionicjoe wrote: All this research is nice but investing in companies and making money at it isn't about publishing research data. A biotech company putting out PRs about their research is akin to a junior gold company informing the market that it is prospecting for gold and has a few good leads. Excuse the market for wanting to wait until a gold deposit is actually found, let alone seeing if they can accomplish the no easy feat of developing a commercial mine.

I guess what I'm saying is don't get carried away with research being a replacement for a CEO having difficulty giving shareholders a return on their investment. Bills need to be paid here and now not sometime in the future. If it's sure money in the bank the market will listen otherwise investors don't pay big money for something that the experts can't even agree on.




Wow, did you really just post that?  How transparent you are.  Poor bash and untimely. Goofy really.  Hope you don't get paid for this one.  Hope your boss is watching these posts.  He needs his $10 back.

Bullboard Posts